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Absence of NOTCH1 gene mutations in MALT lymphomas
The NOTCH family of genes encodes a set of four transmem-
brane receptors that function in cell fate decisions during the
development of many cell types, including B-cells, and recent
studies have indicated an important oncogenic role for
NOTCH activation in various B-cell malignancies (Mirandola
et al, 2011). In particular, NOTCH signalling is known to be
important for the generation of marginal zone B-cells (Hozumi
et al, 2004; Santos et al, 2007). Three subtypes of lymphoma
are believed to derive from marginal zone B-cells: splenic
marginal zone lymphoma (MZL), nodal MZL and the more
common extranodal MZL of mucosa-associated lymphoid
tissue (MALT) (Swerdlow et al, 2008). NOTCH2 mutations
have been reported in B-cell lymphomas, including MZL,
albeit at a low frequency (<5%) (Troen et al, 2008; Lee et al,
2009). Very recently, NOTCH1 mutations have been reported
in chronic lymphocytic leukaemia (CLL) (Fabbri et al, 2011;
Puente et al, 2011). These observations led us to examine the
mutational status of NOTCH1 in a panel of MALT lympho-
mas. We focused on exon 34 of NOTCH1 as it is the most
commonly targeted site for activating mutations that remove
the C-terminal PEST domain, giving rise to a constitutively
active and more stable NOTCH1 protein (Weng et al, 2004;
Fabbri et al, 2011; Puente et al, 2011).
Twenty-three cases of MALT lymphomas were analysed.
Informed consent was obtained in accordance with the
Declaration of Helsinki following the procedures approved
by the local ethical committees and institutional review boards
of each participating institution. The sites of anatomical
involvement were: orbital adnexa (eight cases), stomach (five),
salivary glands (four), skin (four), thyroid, lung (one each).
Seven cases presented involvement of multiple organs. DNA
samples were obtained as previously described (Rinaldi et al,
2011). Whole genome-amplification (WGA) was performed
using 10 ng of DNA per sample and the REPLI-g Mini kit
(Qiagen AG, Hombrechtikon, Switzerland). For polymerase
chain reaction (PCR) amplification of exon 34 of NOTCH1,
5 ll of WGA DNA was used with the following primers:
5¢-TCCACCAGTTTGAATGGTCA-3¢ (forward) and 5¢-AAGG
CTTGGGAAAGGAAGC-3¢ (reverse). A Richter syndrome
(RS) sample known to harbour a heterozygous CT deletion
in exon 34 of NOTCH1 was included as a positive control
(Fabbri et al, 2011). PCR products were purified using the
QIAquick PCR purification kit (Qiagen AG) and Sanger
sequencing of purified PCR products was performed (Micros-
ynth AG, Balgach, Switzerland). Sequence chromatograms
were viewed with 4Peaks Version 1.7.2 (Mekentosj, Aalsmeer,
The Netherlands). All samples had been previously character-
ized for copy number changes with Affymetrix Human
Mapping 250 k arrays (Affymetrix, Santa Clara, CA, USA)
(Rinaldi et al, 2011).
None of the previously reported mutations affecting exon 34
nor any novel mutations were observed, while the heterozy-
gous CT deletion recently reported as present in approximately
10% of B-cell CLL and 31% of RS was observed only in the RS
sample included as a positive control, thereby supporting the
methodology used. Also, the NOTCH1 locus was not a target
of DNA gains, amplifications or copy neutral loss of hetero-
zygosity in the 23 MALT lymphomas (nor in an additional 24
samples) analysed.
Together, these results suggest that activating mutations of
NOTCH1 are not a common pathogenetic mechanism in
MALT lymphomas. It is possible that targeting of other
components of the NOTCH signalling pathway may be more
relevant for MZL. Larger studies investigating other compo-
nents of the NOTCH signalling pathway may shed more light
on the precise contribution of NOTCH signalling to MALT
pathogenesis and possibly open up new treatment avenues for
MALT lymphomas.
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